Sex- and endocrine-stage-differences in middle-aged rats in an animal model of OCD

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 81-87

  Olvera Hernández, Sandra ^a   Chavira, Roberto ^b   Fernández Guasti, Alonso ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

8 OH DPAT; Fluoxetine; Middle age rats; Obsessive compulsive disorder; Spontaneous alternation

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ESTRADIOL; FLUOXETINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIESTRUS; ENDOCRINE FUNCTION; ESTRUS CYCLE; FEMALE; LOCOMOTION; MALE; MAZE TEST; MENSTRUAL IRREGULARITY; MIDDLE AGED; MOBILIZATION; MOTOR COORDINATION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; RAT; ROTAROD TEST; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM; ESTRADIOL; EXPLORATORY BEHAVIOR; FEMALE; FLUOXETINE; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE; MALE; MAZE LEARNING; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOMOTOR PERFORMANCE; RATS; ROTAROD PERFORMANCE TEST; SEROTONIN RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

EID: 84874394180     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.021     Document Type: Article

References (96)

1. Agrati D. Influencia del sexo y del estado reproductivo de la hembra en la respuesta de la rata en un modelo animal del trastorno obsesivo compulsivo. Tesis de maestría, Pedeciba-Biología, Universidad de la República, Montevideo, Uruguay, 2004.
2. Agrati D., Fernández-Guasti A., Zuluaga M.J., Uriarte N., Pereira M., Ferreira A. Compulsive-like behaviour according to the sex and the reproductive stage of female rats. Behav Brain Res 2005, 161:313-319.
3. Albelda N., Joel D. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates. Neurosci Biobehav Rev 2012, 36:47-63.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
5. Avis N.E., Brambilla D., McKinlay S.M., Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994, 4:214-220.
6. Baca E., Garcia-Garcia M., Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:57-65.
7. Baulieu E.E. Androgens and aging men. Mol Cell Endocrinol 2002, 198:41-49.
8. Bestetti G.E., Reymond M.J., Blanc F., Boujon C.E., Furrer B., Rossi G.L. Functional and morphological changes in the hypothalamo-pituitary-gonadal axis of aged female rats. Biol Reprod 1991, 45:221-228.
9. Biegon A., McEwen B.S. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982, 2:199-205.
10. Biegon A., Bercovitz H., Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res 1980, 187:221-225.
11. Bijl R.V., Ravelli A., van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998, 33:587-595.
12. Birzniece V., Johansson I.M., Wang M.D., Seckl J.R., Bäckström T., Olsson T. Serotonin 5-HT(1A) receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 2001, 74:135-142.
13. Blanchard D.C., Shepherd J.K., Rodgers R.J., Blanchard R.J. Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology (Berl) 1992, 106:531-539.
14. Bogetto F., Venturello S., Albert U., Maina G., Ravizza L. Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry 1999, 14:434-441.
15. Bolton J.M., Metge C., Lix L., Prior H., Sareen J., Leslie W.D. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 2008, 28:384-391.
16. Bomholt S.F., Mikkelsen J.D., Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005, 48:252-263.
17. Bongaarts J. Human population growth and the demographic transition. Philos Trans R Soc Lond B Biol Sci 2009, 364:2985-2990.
18. Brocco M., Dekeyne A., Veiga S., Girardon S., Millan M.J. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 2002, 71:667-680.
19. Burke K.C., Burke J.D., Regier D.A., Rae D.S. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 1990, 47:511-518.
20. Calamari J.E., Faber S.D., Hitsman B.L., Poppe C.J. Treatment of obsessive compulsive disorder in the elderly: a review and case example. J Behav Ther Exp Psychiatry 1994, 25:95-104.
21. Callegari C., Buttarelli M., Cromi A., Diurni M., Salvaggio F., Bolis P.F. Female psychopathologic profile during menopausal transition: a preliminary study. Maturitas 2007, 56:447-451.
22. Carlsson M., Carlsson A. In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn Schmiedebergs Arch Pharmacol 1988, 338:345-349.
23. Cohen J.E. Human population: the next half century. Science 2003, 302:1172-1175.
24. Dalla C., Pitychoutis P.M., Kokras N., Papadopoulou-Daifoti Z. Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol 2010, 106:226-233.
25. Darowski A., Chambers S.A., Chambers D.J. Antidepressants and falls in the elderly. Drugs Aging 2009, 26:381-394.
26. David D.J., Bourin M., Hascoët M., Colombel M.C., Baker G.B., Jolliet P. Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) 2001, 153:443-449.
27. Deecher D., Andree T.H., Sloan D., Schechter L.E. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008, 33:3-17.
28. Demeulemeester H., Feys H., Goris I., Zwaenepoel I., de Weerdt W., de Sutter P., et al. Effect of the serotonin agonist 8-OH-DPAT on the sensorimotor system of the rat. Pharmacol Biochem Behav 2001, 70:95-103.
29. Estrada-Camarena E., Martínez-Mota L., Fernández-Guasti A. Sex differences in depression and its treatment. Psychoneuroendocrinology 2011, 97-113. Research Signpost, Kerala. P. de Gortari (Ed.).
30. Fernández-Guasti A., López-Rubalcava C. Modification of the anxiolytic action of 5-HT1A compounds by GABA-benzodiazepine agents in rats. Pharmacol Biochem Behav 1998, 60:27-32.
31. Fernández-Guasti A., Reyes-Serrano R. Perseveration in a T maze as an animal model of obsessive compulsive disorder. Models of neuropharmacology 2009, 119-132. Transworld Reseach Network, Kerala. L.L. Rocha-Arrieta, V. Granados-Soto (Eds.).
32. Fernández-Guasti A., Ulloa R.E., Nicolini H. Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder. Psychopharmacology (Berl) 2003, 166:195-201.
33. Fernández-Guasti A., Agrati D., Reyes R., Ferreira A. Ovarian steroids counteract serotonergic drugs actions in an animal model of obsessive-compulsive disorder. Psychoneuroendocrinology 2006, 31:924-934.
34. Flaisher-Grinberg S., Albelda N., Gitter L., Weltman K., Arad M., Joel D. Ovarian hormones modulate 'compulsive' lever-pressing in female rats. Horm Behav 2009, 55:356-365.
35. Freedman E.M. Neuroendocrine control of the ovarian cycle of the rat. Knobil and Neill's the physiology of reproduction 2006, 2327-2388. Academic Press, San Diego CA. J. Nell (Ed.).
36. Gereau R.W., Kedzie K.A., Renner K.J. Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus. Brain Res Bull 1993, 32:195-201.
37. Gore A.C., Oung T., Yung S., Flagg R.A., Woller M.J. Neuroendocrine mechanisms for reproductive senescence in the female rat: gonadotropin-releasing hormone neurons. Endocrine 2000, 13:315-323.
38. Hanlon J.T., Boudreau R.M., Roumani Y.F., Newman A.B., Ruby C.M., Wright R.M., et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2009, 64:492-498.
39. Hanna G.L. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1995, 34:19-27.
40. Herrera-Pérez J.J., Martinez-Mota L., Fernández-Guasti A. Aging increases the susceptibility to develop anhedonia in male rats. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1798-2003.
41. Herrera-Pérez J.J., Martínez-Mota L., Fernández-Guasti A. Aging impairs the antidepressant-like response to citalopram in male rats. Eur J Pharmacol 2010, 633:39-43.
42. Heyman I., Fombonne E., Simmons H., Ford T., Meltzer H., Goodman R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Int Rev Psychiatry 2003, 15:178-184.
43. Hillegaart V., Estival A., Ahlenius S. Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol 1996, 295:155-161.
44. Hollander E., De Caria C.M., Nitescu A., Gully R., Suckow R.F., Cooper T.B., et al. Serotonergic function in obsessive-compulsive disorder: behavioural and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 1992, 49:21-28.
45. Jovanovic H., Lundberg J., Karlsson P., Cerin A., Saijo T., Varrone A., et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 2008, 39:1408-1419.
46. Kessler R.C., Berglund P., Demier O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
47. Kirmizioglu Y., Doǧan O., Kuǧu N., Akyüz G. Prevalence of anxiety disorders among elderly people. Int J Geriatr Psychiatry 2009, 24:1026-1033.
48. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000, 157:1445-1452.
49. Labad J., Menchón J.M., Alonso P., Segalàs C., Jiménez S., Vallejo J. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 2005, 66:428-435.
50. Labad J., Menchon J.M., Alonso P., Segalas C., Jimenez S., Jaurrieta N., et al. Gender differences in obsessive-compulsive symptom dimensions. Depress Anxiety 2008, 25:832-838.
51. Lensi P., Cassano G.B., Correddu G., Ravagli S., Kunovac J.L., Akiskal H.S. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 1996, 169:101-117.
52. Leonard H.L., Swedo S.E., Rapoport J.L., Koby E.V., Lenane M.C., Cheslow D.L., et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 1989, 46:1088-1092.
53. Liu B., Anderson G., Mittmann N., To T., Axcell T., Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998, 351:1303-1307.
54. Lu K.H., Hopper B.R., Vargo T.M., Yen S.S. Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod 1979, 21:193-203.
55. Matt W.D., Lee J., Sarver P.L., Judd H.L., Lu K. Chronological changes in fertility, fecundity and steroid hormone secretion during consecutive pregnancies in aging rats. Biol Reprod 1986, 34:478-487.
56. Miller M.M., Hyder S.M., Assayag R., Panarella S.R., Tousignant P., Franklin K.B. Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience 1999, 91:1143-1153.
57. Mize A.L., Alper R.H. Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res 2000, 859:326-333.
58. Mundo E., Bareggi S.R., Pirola R., Bellodi L. Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable?. Biol Psychiatry 1999, 45:290-294.
59. Mundo E., Pirola R., Bellodi L., Smeraldi E., Bareggi S.R. Are gender differences in antiobsessional response related to different clomipramine metabolism?. J Clin Psychopharmacol 2002, 23:341-342.
60. Neel J.L., Stevens V.M., Stewart J.E. Obsessive-compulsive disorder: identification, neurobiology, and treatment. J Am Osteopath Assoc 2002, 102:81-86.
61. Nelson J.C., Mazure C.M., Jatlow P.I. Desipramine treatment of major depression in patients over 75years of age. J Clin Psychopharmacol 1995, 15:99-105.
62. Nestadt G., Bienvenu O.J., Cai G., Samuels J., Eaton W.W. Incidence of obsessive-compulsive disorder in adults. J Nerv Ment Dis 1998, 186:401-406.
63. Olvera-Hernández S., Fernández-Guasti A. Sex differences in the burying behavior test in middle-aged rats: effects of diazepam. Pharmacol Biochem Behav 2011, 99:532-539.
64. Parent M., Wallman M.J., Gagnon D., Parent A. Serotonin innervation of basal ganglia in monkeys and humans. J Chem Neuroanat 2011, 41:256-265.
65. Paul C.M., Magda G., Abel S. Spatial memory: theoretical basis and comparative review on experimental methods in rodents. Behav Brain Res 2009, 203:151-164.
66. Pecins-Thompson M., Brown N.A., Kohama S.G., Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 1996, 16:7021-7029.
67. Pigott T.A., Zohar J., Hill J.L. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol Psychiatry 1991, 29:418-426.
68. Piñeyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 1999, 51:533-591.
69. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 1992, 12:440-453.
70. Prior J.C. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998, 19:397-428.
71. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995, 21:103-113.
72. Rasmussen S.A., Eisen J.L. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1990, 51:10-13. [Suppl.].
73. Regier D.A., Boyd J.H., Burke J.D., Rae D.S., Myers J.K., Kramer M., et al. One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988, 45:977-986.
74. Reynolds C.F., Frank E., Kupfer D.J., Thase M.E., Perel J.M., Mazumdar S., et al. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. Am J Psychiatry 1996, 153:1288-1292.
75. Ruscio A.M., Stein D.J., Chiu W.T., Kessler R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbility Survey Replication. Mol Psychiatry 2010, 15:53-63.
76. Ruthazer R., Lipsitz L.A. Antidepressants and falls among elderly people in long-term care. Am J Public Health 1993, 83:746-749.
77. Seibell P.J., Demarest J., Rhoads D.E. 5-HT1A receptor activity disrupts spontaneous alternation behavior in rats. Pharmacol Biochem Behav 2003, 74:559-564.
78. Sershen H., Hashim A., Lajtha A. Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor. Brain Res Bull 2000, 53:353-357.
79. Soares C.N., Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?. J Psychiatry Neurosci 2008, 33:331-343.
80. Stein B.M., Forde R.D., Anderson G., Walker R.J. Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal. Am J Psychiatry 1997, 154:1120-1126.
81. Tolin D.F., Robison J.T., Gaztambide S., Blank K. Anxiety disorders in older Puerto Rican primary care patients. Am J Geriatr Psychiatry 2005, 13:150-156.
82. Tollefson G.D., Rampey A.H., Potvin J.H., Jenike M.A., Rush A.J., Dominguez R.A., et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994, 51:559-567.
83. Tricklebank M.D., Forler C., Fozard J.R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 1984, 106:271-282.
84. Uguz F., Sahingoz M., Gezginc K., Karatayli R. Obsessive-compulsive disorder in postmenopausal women: prevalence, clinical features, and comorbidity. Aust N Z J Psychiatry 2010, 44:183-187.
85. Ulloa R.E., Nicolini H., Fernández-Guasti A. Sex differences on spontaneous alternation in prepubertal rats: implications for an animal model of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:687-692.
86. Umathe S.N., Vaghasiya J.M., Jain N.S., Dixit P.V. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1161-1166.
87. Vestergaard P., Rejnmark L., Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 2006, 17:807-816.
88. vom Saal S.F., Finch E.C. Reproductive senescence: phenomena and mechanisms in mammals and selected vertebrates. The physiology of reproduction 1988, 2351-2413. Raven Press, New York. E. Knobil, J. Nell (Eds.).
89. Vulink N.C., Denys D., Bus L., Westenberg H.G. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 2006, 21:171-175.
90. Whitaker-Azmitia P.M., Molino L.J., Caruso J., Shemer A.V. Serotonergic agents restore appropriate decision-making in neonatal rats displaying dopamine D1 receptor-mediated vacillatory behavior. Eur J Pharmacol 1990, 180:305-309.
91. Wikinski S.I., Acosta G.B., Gravielle M.C., Bonavita C.D., Bisagno V., Fiszer de Plazas S., et al. Diazepam fails to potentiate GABA-induced chloride uptake and to produce anxiolytic-like action in aged rats. Pharmacol Biochem Behav 2001, 68:721-727.
92. Williams K.E., Koran L.M. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997, 58:330-334.
93. Wise P.M., Ratner A. Effect of ovariectomy on plasma LH, FSH, estradiol, and progesterone and medial basal hypothalamic LHRH concentrations old and young rats. Neuroendocrinology 1980, 30:15-19.
94. Yadin E., Friedman E., Bridger W.H. Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder?. Pharmacol Biochem Behav 1991, 40:311-315.
95. Zohar J., Mueller E.A., Insel T.R. Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 1987, 44:946-951.
96. Zohar J., Zohar-Kadouch R.C., Kindler S. Current concepts in the pharmacological treatment of obsessive-compulsive disorder. Drugs 1992, 43:210-218.